Navigation Links
National Press Club to Host "NEWSMAKER" with PhRMA CEO to Discuss Policy, Budget Threats to Biopharmaceutical Research

WASHINGTON, Sept 6, 2012 /PRNewswire-USNewswire/ -- This year, the biopharmaceutical research industry will have invested $500 billion in research and development since 2000. In 2011, research and development in the biopharmaceutical sector represented 20 percent of all research and development undertaken by American businesses. This investment by a single industry is one of the reasons that the U.S. leads the world in R&D.  However, in a time of uncertainty when the country is facing major policy decisions that will shape the future of health care and our economy, what must happen to sustain this investment and the work of the researchers who drive it?


John Castellani, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), will discuss the need for policies that support innovation as a key component of the nation's economic and health future, the questions facing policymakers today, and the important work of biopharmaceutical researchers in a National Press Club Newsmaker press conference 10:00 a.m.., Thursday, September 20, 2012, National Press Building, 529 14th St., NW, Washington, D.C.

Castellani will mark the progress made as a result of the $500 billion investment in the 2000's and look ahead at how the industry and the broader health care ecosystem can build upon that success.

SOURCE National Press Club
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
2. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
5. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
6. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
7. Fuse Science Partners With GNC To Open National Distribution Of EnerJel™
8. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
9. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
10. WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day
11. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
Post Your Comments:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... process to promote standards of excellence for the field of eating disorders, announces ... 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):